ID
29055
Descrizione
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Keywords
versioni (5)
- 05/10/17 05/10/17 -
- 22/02/18 22/02/18 -
- 22/02/18 22/02/18 -
- 22/02/18 22/02/18 -
- 17/09/21 17/09/21 -
Titolare del copyright
gsk
Caricato su
22 febbraio 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Ropinirole Case Report Form GSK RRL100013
STATUS OF TREATMENT BLIND
Descrizione
PGx-PHARMACOGENETIC RESEARCH INSTRUCTIONS
Descrizione
The question "Has informed consent been obtained for PGx-Pharmacogenetic research?" should be completed at the beginning of the study. If the question is answered No, I/ one box for reason and do not complete the remainder of the page. WITHDRAWAL OF CONSENT The question "Has the subject withdrawn consent for PGx-Pharmacogenetic research?" must be completed immediately if the subject withdraws consent. Otherwise, it must be completed when the subject leaves the study. It must be completed for all subjects for whom informed consent was obtained for PGx-Pharmacogenetic research. If consent is withdrawn, a request for destruction must be made and Blood Sample Destruction section below completed. BLOOD SAMPLE DESTRUCT/ON Do not complete this section if a blood sample was not collected. The question "Has a request been made for sample destruction?" must be completed immediately if there is a request for sample destruction. Otherwise, it must be completed when the subject leaves the study. It must be completed for all subjects for whom a blood sample was obtained for PGx-Pharmacogenetic research. If the question is answered Yes, I/one box for reason.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0031325
- UMLS CUI [1,2]
- C1442085
Descrizione
PGx-PHARMACOGENETIC RESEARCH
Descrizione
CONSENT FOR PGx-PHARMACOGENETIC RESEARCH
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Descrizione
Informed consent if yes
Tipo di dati
date
Alias
- UMLS CUI [1]
- C2985782
Descrizione
Informed consent if no
Tipo di dati
text
Alias
- UMLS CUI [1]
- C0021430
Descrizione
BLOOD SAMPLE COLLECTION
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0005834
Descrizione
If Yes, record the date sample taken
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C0011008
Descrizione
WITHDRAWAL OF CONSENT
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C1707492
Descrizione
BLOOD SAMPLE DESTRUCTION
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
Descrizione
If Yes: BLOOD SAMPLE DESTRUCTION
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
Descrizione
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the Concomitant Medications page. These are not all inclusive lists and are for guidance only, other abbreviations not listed may be used if necessary.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2347852
Descrizione
UNITS
Tipo di dati
text
Alias
- UMLS CUI [1]
- C1519795
Similar models
STATUS OF TREATMENT BLIND
C2347038 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C1442085 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)